South Wales, July 25 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "AUK Biobridge" on June 30. The details about the trademark application no. UK00004226533 published in the journal no. 2025/030 (July 25).
With HGF Limited as representative, Medicines Discovery Catapult Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Mobile telephone software, software to enable the viewing of website content via personal and handheld computers and mobile devices; downloadable software in the nature of a mobile application; downloadable mobile application software; downloadable software for use in wireless telecommunication devices; computer software; publications in electronic form supplied on-line from a database or from facilities provided on the Internet or other network (including websites); computer software and downloadable software in the nature of a mobile application and downloadable mobile application software relating to drug discovery services, pharmaceutical drug development services and medical, pharmaceutical research and development; electronic publications; information stored on electronic, magnetic and/or optical means.
Class 35 : Business networking services; business consultancy and business advisory services; compilation and provision of business, trade and business information; business and commercial forecasting services; business and commercial research services; business management services; advisory, consultancy and information services relating to all the aforesaid.
Class 41 : Conference services; educational networking services; organisation of meetings, seminars, symposiums and conferences; provision of education, instructional and teaching services; publication and distribution of printed media and recordings; publication of the results of clinical trials for pharmaceutical preparations; advisory, consultancy and information services relating to all the aforesaid.
Class 42 : Drug discovery services; pharmaceutical drug development services; medical, pharmaceutical and vaccine research and development; development of pharmaceutical preparations and medicines; clinical trials; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical products development; pharmaceutical product evaluation; providing information about the results of clinical trials for pharmaceutical products; laboratory research services relating to pharmaceuticals; laboratory research; translational imaging services use in drug and pharmaceutical research and development and in relation to the investigation and research of biochemical and biological processes; pre-clinical imaging services; mass spectrometry and In vivo imaging services; spatial transcriptomic services; therapeutic response modelling; virtual drug, medical and pharmaceutical research services; design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services; bioinformatics, cheminformatics and bioimaging informatics services; services for software development, software updating, design, installation, maintenance and rental of software; computer software design and development services; design and development of mobile application software; application service provider (ASP) services; providing temporary use of non-downloadable software; providing temporary use of non-downloadable software to enable the viewing of website content via personal and handheld computers and mobile devices; provision of non-downloadable software applications through a website, virtual community, social networking site, shared use of text, images and audio-visual content; rental and maintenance of memory space for others (hosting), software development services; providing temporary use of non-downloadable software; providing temporary use of non-downloadable software to enable the viewing of website content via personal and handheld computers and mobile devices relating to drug discovery services, pharmaceutical drug development services and medical, pharmaceutical research and development; scientific and technological research relating to patent mapping; scientific research relating to cosmetics; testing of pharmaceuticals; providing scientific research information and results from an online searchable database; preparation of scientific reports; preparation of reports relating to scientific research; compilation of scientific information; advisory, consultancy and information services relating to all the aforesaid.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004226533
Disclaimer: Curated by HT Syndication.
